Literature DB >> 24911606

Transoral robotic supraglottic partial laryngectomy.

Fatma Tülin Kayhan1, Kamil Hakan Kaya, Ahmet Altintas, Ibrahim Sayin.   

Abstract

OBJECTIVE: Transoral robotic supraglottic laryngectomy is a new surgical way to perform endolaryngeal resection of supraglottic laryngeal carcinoma. The aim of this report was to present our initial experience about transoral robotic supraglottic laryngectomy for early supraglottic cancer.
METHODS: Subjects with early squamous cell carcinoma (T1-T2) of supraglottic region who managed using transoral robotic surgery in a tertiary referral center were included in the study. The technique of robot-assisted resection, intraoperative blood loss, mean robotic operating time, pathologic margin status, postoperative extubation, need for a tracheotomy, and length of hospitalization, complications, duration of oral nutrition, and neck dissection and radiotherapy needs were evaluated.
RESULTS: Thirteen subjects (12 men, 1 woman) with T1-T2 supraglottic carcinoma were successfully operated on with transoral robotic surgery. In all subjects, negative margins were obtained. The mean total robotic surgery time was 31.6 (SD, 16.2) minutes (range, 20-80 minutes). Mean total blood loss was less than 40 mL. Subjects started oral nutrition with a mean of 10.8 (SD, 8.9) days (range, 4-30 days) postoperatively. The mean hospitalization was 15.4 (SD, 10.4) days (range, 7-42 days). CONCLUSIONS AND RELEVANCE: Transoral robotic supraglottic laryngectomy with the da Vinci robotic system can be regarded as a feasible, safe, and effective technique. Although short-term results seem discouraging, long-term results are needed to evaluate the oncologic safety.

Entities:  

Mesh:

Year:  2014        PMID: 24911606     DOI: 10.1097/SCS.0000000000000572

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  8 in total

1.  Combined laser and robotic approach for the management of a mixed laryngomucocele.

Authors:  Q Lisan; C Hoffmann; T Jouffroy; S Hans
Journal:  J Robot Surg       Date:  2015-12-08

Review 2.  Minimally Invasive Procedures for Laryngeal Carcinoma: Transoral Endoscopic Laser and Transoral Robotic Surgery.

Authors:  Özgül Topal
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01

3.  Functional and Oncological Outcomes of Open Partial Laryngectomy vs. Transoral Laser Surgery in Supraglottic Larynx Cancer.

Authors:  Muhammet Fatih Gökmen; Zahide Çiler Büyükatalay; Süha Beton; Mustafa Kürşat Gökcan; Gürsel Dursun; Cem Meço; Tarık Babür Küçük
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-12-01

4.  Airway management during transoral robotic surgery for head and neck cancers: a French GETTEC group survey.

Authors:  Valentine Poissonnet; Emilien Chabrillac; Philippe Schultz; Sylvain Morinière; Philippe Gorphe; Bertrand Baujat; Renaud Garrel; Audrey Lasne-Cardon; Alexandre Villeneuve; Guillaume Chambon; Nicolas Fakhry; Karine Aubry; Xavier Dufour; Olivier Malard; Romina Mastronicola; Benjamin Vairel; Patrice Gallet; Philippe Ceruse; Franck Jegoux; Jean Ton Van; Guillaume De Bonnecaze; Sébastien Vergez
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-23       Impact factor: 2.503

5.  The First Successful Case of Transoral Robotic Surgery in a Patient with Sialadenoma Papilliferum.

Authors:  Arzu-Karaman Koç; Yakup Yegin; Mustafa Çelik; Mehmet Sar; Damlanur Sakiz; Fatma-Tülin Kayhan
Journal:  Iran J Otorhinolaryngol       Date:  2016-09

Review 6.  Evidence and evidence gaps of laryngeal cancer surgery.

Authors:  Susanne Wiegand
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

7.  Management of the Airway for Transoral Robotic Supraglottic Partial Laryngectomy.

Authors:  Vanessa C Stubbs; Karthik Rajasekaran; Adam R Gigliotti; Ahmad F Mahmoud; Robert M Brody; Jason G Newman; Christopher H Rassekh; Gregory S Weinstein
Journal:  Front Oncol       Date:  2018-08-14       Impact factor: 6.244

Review 8.  A Contemporary Review of Evidence for Transoral Robotic Surgery in Laryngeal Cancer.

Authors:  Philippe Gorphe
Journal:  Front Oncol       Date:  2018-04-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.